Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study in Patients Undergoing Cardiac Surgery to Evaluate the Effect of Bolus Clevidipine Administration (SPRINT)

NCT00799604 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT00799604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00799604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study in Patients Undergoing Cardiac Surgery to Evaluate the Effect of Bolus Clevidipine Administration (SPRINT)
Lead sponsor
The Medicines Company
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
October 31, 2009
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension